SCHEMBL24577288

SCHEMBL24577288

Cc1ncc(NC(=O)CN2CC(C)(C)C2)cc1NC(=O)c1cnn2cc(-c3cn[nH]c3)sc12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ WNT1 P04628 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CHRM1 P11229 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ WNT3A P56704 2/20 0.31
▸ POLQ O75417 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.30
▸ JAK1 P23458 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ KIT P10721 1/20 0.30
▸ IKBKE Q14164 1/20 0.30
▸ TBK1 Q9UHD2 1/20 0.30
▸ DNM1L O00429 1/20 0.30
▸ LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759858 1.00 WNT1 (0.35) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL24577805 0.90 GSK3B (0.38) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL30897504 0.90 GSK3B (0.38) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL29759476 0.89 GSK3B (0.45) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL27185243 0.89 GSK3B (0.45) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL30897478 0.89 WNT1 (0.36) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL27185018 0.89 WNT1 (0.36) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL29760098 0.88 WNT1 (0.38) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL24577748 0.88 GSK3B (0.38) WNT1GSK3BDYRK1ACHRM1PDGFRA
SCHEMBL29759826 0.88 WNT1 (0.36) WNT1GSK3BDYRK1ACHRM1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback